Losartan not only blocks TGF-β signaling but also prevents angiotensin II signaling by blocking AT1Rs, which may be activated in some forms of aneurysm.26 It is a reasonable speculation that ARBs may have beneficial effects in the treatment of more common nonhereditary AAs. The gene discussed is TGFB1; the disease is aneurysm.